Emerging technologies for point-of-care genetic testing.
In the coming years, genetic test results will be increasingly used as indicators that influence medical decision making. Novel instrumentation that is able to detect relevant mutations in a point-of-care setting is being developed to facilitate this increase, frequently as a spin-off from recent research in the area of biothreat monitoring. This market review will describe the current generation of instrumentation that is most suitable for use in a point-of-care setting; it will also try to identify some of the technologies that will make-up the next generation of instrumentation currently being prepared for the market.
Dobson
Mark G
MG
National Centre for Medical Genetics, University College Dublin, Our Lady's Children's Hospital, Crumlin, Dublin 12, Ireland. mark.dobson@ucd.ie
Galvin
Paul
P
Barton
David E
DE
D030342:Genetic Diseases, Inborn / Q000175:diagnosis*; D005819:Genetic Markers; D006801:Humans; D025202:Molecular Diagnostic Techniques / Q000295:instrumentation / Q000379:methods / Q000639:trends; D020411:Oligonucleotide Array Sequence Analysis / Q000295:instrumentation / Q000379:methods / Q000639:trends; D019095:Point-of-Care Systems / Q000639:trends
D005819:Genetic Markers